Ultragenyx Pharmaceutical Inc. (RARE) Earnings
NASDAQ·Healthcare·Biotechnology
$14.94
-4.32%
Mkt Cap $1.54B
EPS — Estimate vs Actual
Mkt Cap
$1.54B
P/E
—
Fwd P/E
—
P/S
2.30
Rev TTM
—
EPS TTM
-$6.11
NASDAQ·Healthcare·Biotechnology
$14.94
-4.32%
Mkt Cap $1.54B
Mkt Cap
$1.54B
P/E
—
Fwd P/E
—
P/S
2.30
Rev TTM
—
EPS TTM
-$6.11